jcovden (previously covid-19 vaccine janssen)
janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccinuri - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. utilizarea acestui vaccin ar trebui să fie în conformitate cu recomandările oficiale.
rybrevant
janssen-cilag international n.v. - amivantamab - carcinom, pulmonar non-celulă mică - agenți antineoplazici - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
lumykras
amgen europe bv - sotorasib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
uptravi 200 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 200 mcg
uptravi 400 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 400 mcg
uptravi 600 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 600 mcg
uptravi 1000 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1000 mcg
uptravi 1200 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1200 mcg
uptravi 1400 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1400 mcg
uptravi 1600 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1600 mcg